Myelodysplastic Syndrome in a Case of New-onset Pancytopenia

Authors

Ian Lancaster, HCA HealthcareFollow
Deep Patel, HCA HealthcareFollow
Vikas Sethi, HCA HealthcareFollow
Weston Connelly, HCA HealthcareFollow
Joseph Namey Jr., HCA HealthcareFollow

Division

West Florida

Hospital

Largo Medical Center

Document Type

Case Report

Publication Date

3-1-2022

Keywords

myelodysplastic syndrome, pancytopenia, piperacillin/tazobactam‐induced immune response, vaccine‐associated pancytopenia

Disciplines

Hemic and Lymphatic Diseases | Internal Medicine

Abstract

Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.

Publisher or Conference

Clinical Case Reports

Recommended Citation

Lancaster I, Patel D, Sethi V, Connelly W, Namey J. Myelodysplastic syndrome in a case of new-onset pancytopenia. Clin Case Rep. 2022;10(3):e05533. doi:10.1002/ccr3.5533